AngioDynamics posts Q2 net sales increases

2016 12 23 14 10 03 523 Graph Bar Arrow Up 400

Interventional technology developer AngioDynamics has posted net sales increases for both its second quarter and six-month periods.

For the quarter (end-November 30), the company had net sales of $85.4 million, a 9.1% increase compared with $78.3 million in the same period in 2021. Medical device net sales increased 2.6%, from $59.4 million in 2021 to $60.9 million. However, the company posted a net loss of $8.5 million, up slightly from 2021's $8.3 million.

For the company's six-month results, it posted net sales of $166.9 million, up 7.5% compared with $155.2 million in 2021. It posted a net loss for the six-month period of $21.5 million, an increase compared with 2021's $15.3 million. Its medical device division reported net sales of $119.6 million for the six-month period, up 0.7% compared with 2021's $118.7 million.

Page 1 of 3426
Next Page